In a news release, Reliq Health Technologies Inc. (RHT:TSX.V; RQHTF:OTCQB) announced that the 2020 TSX Venture 50 recognized it as one of the top 10 companies in the technology sector on the stock exchange over the previous year.
The 2020 TSX Venture 50 selects and ranks the top 10 companies in each of the five industry sectors trading on the exchange, based on three, equally weighted measures: market capitalization growth, share price appreciation and trading volume.
"It is truly an honor to receive this recognition from the TSX Venture Exchange," Reliq CEO Dr. Lisa Crossley said in the release. "We look forward to building on our success to date and continuing to deliver significant value for our shareholders."
Reliq is a "technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare," the company stated.
[NLINSERT]Disclosure:
1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Reliq Health Technologies, a company mentioned in this article.
